AGP Limited (PSX:AGP)
Pakistan · Delayed Price · Currency is PKR 179.95
-0.06 (-0.03%)
At close: Mar 27, 2026
AGP Limited Revenue
In the year 2025, AGP Limited had annual revenue of 28.89B PKR with 15.40% growth. AGP Limited had revenue of 8.55B in the quarter ending December 31, 2025, with 15.77% growth.
Revenue
28.89B
Revenue Growth
+15.40%
P/S Ratio
1.74
Revenue / Employee
13.48M
Employees
2,143
Market Cap
50.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.89B | 3.86B | 15.40% |
| Dec 31, 2024 | 25.03B | 6.29B | 33.56% |
| Dec 31, 2023 | 18.74B | 4.28B | 29.63% |
| Dec 31, 2022 | 14.46B | 5.14B | 55.19% |
| Dec 31, 2021 | 9.32B | 2.37B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 75.40B |
| GlaxoSmithKline Pakistan | 62.07B |
| The Searle Company | 33.26B |
| Highnoon Laboratories | 26.61B |
| Ferozsons Laboratories | 22.22B |
| Citi Pharma | 14.10B |
| Macter International | 11.58B |
| Otsuka Pakistan | 4.26B |